[PDF] Top 20 Diagnostic challenges in multiple system atrophy

... Abstract: Multiple system atrophy is a progressive neurodegenerative disorder that is characterized by autonomic failure, cerebellar ataxia and parkinsonism syndrome in various ...for multiple ... See full document

... After death, consent of the next of kin was obtained for brain removal following local Ethical Committee procedure and the 1964 Declaration of Helsinki (as revised in Edinburgh, 2000). A block of the right cerebellar ... See full document

... The early stage of MSA can be difficult to distinguish from Parkinson’s disease [4]. Our case confirms that DBS is largely ineffective in MSA, as previously reported [13]. Future studies to develop early ... See full document

... se diagnostic of either MSA or SRO disease although they are more typically observed in ...olivopontocerebellar atrophy in the 35 UKPDSBB MSA cases (chapter ... See full document

... in multiple system atrophy and progressive supranuclear palsy needs large-scale pro- spective studies with pathological confirmation of diagnosis where ...with multiple system ... See full document

... Multiple system atrophy (MSA) is a sporadic, pro- gressive neurodegenerative disorder of adult onset characterized by any combination of Parkinsonism, autonomic, cerebellar, and pyramidal symptoms ... See full document

... MSA-P diagnostic subgroups were detected by TBSS, we elected to additionally evaluate DTI metrics in the basal ganglia (caudate nucleus, putamen, and globus pallidus) of MSA and control ... See full document

... Biomarkers include those based on neuroimaging, in particular multimodal magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), MR spectroscopy, and positron emission tomography (PET), peripheral biomarkers ... See full document

... (PSP), multiple system atrophy (MSA), and corticobasal degeneration (CBD), and are characterized by rapid disease progression and decreased life ...healthcare system and patients attributable ... See full document

... Finally, there are some limitations to our study that should be addressed. First, definite MSA requires post- mortem (autopsy) confirmation of α-synuclein-positive inclusions in oligodendrocytes. However, we could not ... See full document

... PD is differentiated from other forms of Parkinsonism, including MSA and PSP by defining clinical criteria’s as no reliable diagnostic biomarkers have been described yet. The differences in the cognitive profile ... See full document

... pontine atrophy in the present ...between atrophy or perfusion changes measured by the present technique and disease severity may be necessary in a lar- ger number of ...local atrophy may be ... See full document

... The current model of tissue spread of α-syn pathology, devised by Braak et al., in 2003 proposed that LB in sporadic PD originate within the olfactory bulb and medulla oblongata and later spread to the substantia nigra, ... See full document

... Brain atrophy rates are higher in those CIS patients who subsequently develop MS compared with those who remain CIS [50, ...of Multiple Sclerosis) trial, a difference in median annual PBVC was found between ... See full document

... MSA-SDS is characterized by autonomic nervous system failure (orthostatic hypotension, urinary incontinence, and inability to sweat). Although the pathologic changes are somewhat variable, neuronal loss in the ... See full document

... In addition, EDS has been considered a common manifestation of multiple system atrophy (MSA) [3,4]. MSA patients can develop sleep-disordered breathing (SDB), which is associated with upper-airway ... See full document

... brain atrophy in DLB resembles that of Alzheimer’s disease (AD) 24 but the size of the parietal, frontal, and temporal lobes is often intermediate between those of AD and control ...limbic system including ... See full document

... and the caudate nucleus are severely affected, with a se- lective involvement of GABAergic medium spiny neu- rons [97]. Substantia nigra dopaminergic neurons are also remarkably involved in the degenerative process and a ... See full document

... A 54-year-old man was taking talutireline hydrate for MSA that was diagnosed at the age of 51 years. The diagnosis of MSA by an experienced neurologist was based on trunk disorder, swallowing disorder, dysarthria, and ... See full document

... For direct sequence analysis, each exon was amplified by polymerase chain reaction (PCR) using published primers for COQ2 [4]. DNA was extracted from frozen brain or whole blood samples using standard protocols. ... See full document